Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2022
Net cash position 2022
P/E ratio 2022
Net income 2023
Net cash position 2023
P/E ratio 2023
EV / Sales 2022
EV / Sales 2023
Nbr of Employees
Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Companyâ€™s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of...
Ratings of Homology Medicines, Inc.
All news about HOMOLOGY MEDICINES, INC.
09/16 Homology Medicines : Corporate Presentation - September 2022
09/12 Homology Medicines : Corporate Presentation - September 2022
09/08 Homology Medicines, Inc. : Change in Directors or Principal Officers, Financial Statements..
09/06 Homology Medicines Promotes Chief Scientific Officer Albert Seymour to CEO
09/06 Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer
09/06 Homology Medicines, Inc. Appoints Albert Seymour as Chief Executive Officer
09/06 Homology Medicines, Inc. Announces Promotion of Albert Seymour to Member of the Board o..
09/01 Homology Medicines : Corporate Presentation - September 2022
08/31 Baird Adjusts Price Target on Homology Medicines to $9 From $10, Keeps Outperform Ratin..
08/16 Chardan Lowers Homology Medicines' Price Target to $10 From $14, Maintains Buy Rating
08/16 BTIG Adjusts Price Target on Homology Medicines to $12 From $29, Reiterates Buy Rating
08/15 Homology Medicines : Q2 Earnings Snapshot
08/15 HOMOLOGY MEDICINES, INC. Management's Discussion and Analysis of Financial Condition a..
08/15 Homology Medicines Reports Second Quarter 2022 Financial Results, Recent Highlights and..
08/15 Homology Medicines, Inc. Reports Earnings Results for the Second Quarter and Six Months..
News in other languages on HOMOLOGY MEDICINES, INC.
Analyst Recommendations on HOMOLOGY MEDICINES, INC.
ETFs positioned on HOMOLOGY MEDICINES, INC. ETFs and Trackers with Trackinsight
Chart HOMOLOGY MEDICINES, INC.
Technical analysis trends HOMOLOGY MEDICINES, INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target